Matt Hasselbeck Joins Boston University Study on CTE Diagnosis
Former NFL quarterback Matt Hasselbeck is participating in a study at Boston University to help researchers find a way to diagnose Chronic Traumatic Encephalopathy (CTE) in living individuals. The study aims to differentiate CTE from Alzheimer's disease by analyzing data…
Denver, CO, August 12, 2026 —
Former NFL quarterback Matt Hasselbeck is lending his participation to a significant research effort at Boston University, aimed at developing methods to diagnose Chronic Traumatic Encephalopathy (CTE) in living individuals. This initiative seeks to address a critical gap in understanding and treating neurodegenerative conditions often associated with repetitive head impacts.
The study’s primary objective is to distinguish CTE from Alzheimer’s disease, a condition that shares some overlapping symptoms but has different underlying causes and potential treatments. Researchers at Boston University are collecting and analyzing data from a cohort that includes former professional football players, as well as individuals who have already been diagnosed with Alzheimer’s disease.
By examining the data from these diverse groups, the research team hopes to identify reliable biomarkers and diagnostic patterns that can accurately differentiate between CTE and Alzheimer’s. The ultimate goal of this work is to pave the way for the development of precise diagnostic tools, which are currently lacking for CTE in living persons. Such advancements would be crucial for enabling timely interventions and informing the development of targeted treatments for those affected by CTE.
The participation of former athletes like Hasselbeck is vital for gathering the comprehensive data necessary for this complex research. CTE has become a growing concern within the sports community, particularly in contact sports like American football, due to its potential long-term neurological consequences.
Researchers involved in the study emphasize the importance of differentiating CTE from other neurodegenerative diseases to ensure appropriate care and management strategies are implemented for patients. The findings from this Boston University study are anticipated to contribute significantly to the ongoing scientific effort to understand and combat the effects of traumatic brain injuries.
Story summarized from the original created by AP via Scripps News Group on www.denver7.com, see more information here.
